Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant

Publisher： Karger

E-ISSN： 1423-0194|105|1|44-53

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.105, Iss.1, 2016-07, pp. : 44-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression and Function of Somatostatin Receptor Subtype 1 in Human Growth Hormone Secreting Pituitary Tumors Deriving from Patients Partially Responsive or Resistant to Long-Term Treatment with Somatostatin Analogs

By  

Neuroendocrinology, Vol. 79, Iss. 3, 2004-05 ,pp. : 142-148

Karger

Access to resources Recommend Favorite

Thyroid Hormones Regulate the Expression of Somatostatin Receptor Subtypes in the Rat Pituitary

By  

Neuroendocrinology, Vol. 69, Iss. 6, 1999-06 ,pp. : 460-464

Karger

Access to resources Recommend Favorite

Somatostatin and Dopamine-Somatostatin Multiple Ligands Directed towards Somatostatin and Dopamine Receptors in Pituitary Adenomas

By  

Neuroendocrinology, Vol. 83, Iss. 3-4, 2006-10 ,pp. : 258-263

Karger

Access to resources Recommend Favorite

Preferential Expression of sst2A over sst2B Somatostatin Receptor Splice Variant in Rat Brain and Pituitary

By  

Neuroendocrinology, Vol. 68, Iss. 1, 2008-03 ,pp. : 37-43

Karger

Access to resources Recommend Favorite

Use of Long-Acting Somatostatin Analogue (Lanreotide) in an Adolescent with Diazoxide-Responsive Congenital Hyperinsulinism and Its Psychological Impact

By  

Hormone Research in Paediatrics, Vol. 84, Iss. 5, 2015-0 ,pp. : 355-360

Karger

Access to resources Recommend Favorite